Vor Biopharma Inc
Vor Biopharma Inc (VOR) Covered Calls
As of September 25, 2026, VOR has 16 covered call opportunities in the coming three months. Return ranges from 4.8 to 81.2% until expiration. Annualized return ranges from 30.2 to 469.5%. The nearest expiration is October 16, 2026. Maximum potential profit is $1,573.
Read more
Running VOR covered calls helps you generate consistent income from Vor Biopharma Inc's shares you already own, turning a long stock position into a yield-producing asset. A covered call on Vor Biopharma Inc involves holding the underlying stock and selling a call option against it, collecting premium in exchange for capping upside at the strike price. Use our scanner to find the best VOR covered calls in real time and filter for the strikes, expiries, and premiums that fit your strategy.
A covered call is one of the most widely used options strategies because it pairs limited risk with a clear income profile: if VOR stays below the strike at expiration, you keep the premium and the shares; if it rises above, you deliver the stock at the strike and still pocket the premium. Selling VOR covered calls works best when implied volatility is elevated, since richer premiums improve the risk-reward. Key inputs to evaluate include strike selection relative to delta, days to expiration, annualized return, and the probability of assignment — all of which determine whether a given Vor Biopharma Inc covered call is worth writing.
Income-focused investors, long-term VOR holders, and systematic premium sellers all face the same challenge: finding the covered call strike and expiry that balances yield against the risk of being called away. Our scanner ranks covered calls by annualized return, downside protection, and probability of profit, so selling VOR covered calls becomes a measured decision instead of a guess. Stop eyeballing the chain — let the best Vor Biopharma Inc covered calls come to you, already filtered for the metrics that matter.
Stock Statistics
- IndustryBiotechnology
- SectorHealthcare
- IV percentile—
- Market cap (M$)1,096
- 52 weeks high-62.92%
- 52 weeks low184.92%
- Analyst recommendationStrong Buy
1.33 - Target price$39.00
110.58% above the current stock price - Dividend—
- Payout ratio—
- Earnings date2026-11-12
- P/E—
- Future P/E—
- EPS (ttm)-83.39
- EPS growth next 5 years61.82%
As of September 25, 2026
| 2026-10-16 | 23 | 25.00 | 29.07 | 0.10 | 2.75 | 573.00 | 29.58 | 469.45 | -0.52 | +0.34 | 41 | 2.65 |
| 2026-11-20 | 58 | 30.00 | 54.88 | 0.15 | 4.60 | 1078.00 | 55.65 | 350.23 | -0.77 | +0.37 | 111 | 4.45 |
| 2026-10-16 | 23 | 22.50 | 16.16 | 0.25 | 2.35 | 338.00 | 17.45 | 276.92 | -1.29 | +0.37 | 269 | 2.10 |
| 2027-02-19 | 149 | 35.00 | 80.69 | 0.10 | 4.90 | 1573.00 | 81.21 | 198.93 | -0.52 | +0.36 | 11 | 4.80 |
| 2026-11-20 | 58 | 25.00 | 29.07 | 0.10 | 2.50 | 573.00 | 29.58 | 186.16 | -0.52 | +0.32 | 9 | 2.40 |
| 2027-02-19 | 149 | 30.00 | 54.88 | 0.50 | 4.90 | 1113.00 | 57.46 | 140.76 | -2.58 | +0.40 | 18 | 4.40 |
| 2027-05-21 | 240 | 30.00 | 54.88 | 3.00 | 6.00 | 1363.00 | 70.37 | 107.02 | -15.49 | +0.51 | 200 | 3.00 |
| 2026-11-20 | 58 | 22.50 | 16.16 | 0.10 | 4.90 | 323.00 | 16.68 | 104.94 | -0.52 | +0.47 | 13 | 4.80 |
| 2026-10-16 | 23 | 20.00 | 3.25 | 0.60 | 4.90 | 123.00 | 6.35 | 100.77 | -3.10 | +0.55 | 2 | 4.30 |
| 2027-02-19 | 149 | 25.00 | 29.07 | 2.00 | 4.80 | 763.00 | 39.39 | 96.49 | -10.33 | +0.49 | 13 | 2.80 |
As of September 25, 2026
Sell covered calls with the data behind you
Find the best VOR covered call setups ranked by annualized return, filter by premium, delta, and days to expiration, and act on the opportunity in seconds.
Start your 14-day free trial→